Evidence map›Paper›PMID 27094595›Full record

ArticleRheumatology (Oxford, England)2016

Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Humaira Rasheed, Amanda J Phipps-Green, Ruth Topless, Malcolm D Smith, Catherine Hill, Susan Lester, Maureen Rischmueller, Matthijs Janssen, Timothy L Jansen, Leo A Joosten and 12 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Rheumatology (Oxford, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Autoinflammatory Features in Gouty Arthritis.Journal of clinical medicine · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 9 countries.

Humaira RasheedDepartment of Biochemistry, University of Otago, Dunedin, New Zealand Department of Chemistry, University of Engineering and Technology, Lahore, Pakistan.
Amanda J Phipps-GreenDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Ruth ToplessDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Malcolm D SmithDepartment of Medicine, Flinders Medical Centre and Repatriation General Hospital, Adelaide.
Catherine HillRheumatology Department, The Queen Elizabeth Hospital, Woodville South, SA, Australia.
Susan LesterRheumatology Department, The Queen Elizabeth Hospital, Woodville South, SA, Australia.
Maureen RischmuellerRheumatology Department, The Queen Elizabeth Hospital, Woodville South, SA, Australia.
Matthijs JanssenDepartment of Rheumatology, Rijnstate Hospital, Arnhem.
Timothy L JansenDepartment of IQ HealthCare, VieCuri Medical Centre, Venlo.
Leo A JoostenDepartment of Internal Medicine and Radboud Institute of Molecular Life Science, Radboud University Medical Center, Nijmegen.
Timothy R RadstakeDepartment of Rheumatology and Clinical Immunology, Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Philip L RichesRheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Anne-Kathrin TauscheDepartment of Rheumatology, University Clinic Carl-Gustav-Carus, Dresden, Germany.
Frederic LiotéINSERM, UMR-S 1132, Hospital Lariboisière University Paris Diderot (UFR de Médecine), Sorbonne Paris Cité, Paris, F-75205, France.
Alexander SoDAL, Service of Rheumatology, Laboratory of Rheumatology, University of Lausanne, CHUV, Nestlé 05-5029, Lausanne, Switzerland.
Andre van RijDepartment of Surgery, University of Otago, Dunedin.
Gregory T JonesDepartment of Surgery, University of Otago, Dunedin.
Sally P McCormickDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Andrew A HarrisonDepartment of Medicine, University of Otago, Wellington.
Lisa K StampDepartment of Medicine, University of Otago, Christchurch.
Nicola DalbethDepartment of Medicine, University of Auckland, Auckland, New Zealand.
Tony R MerrimanDepartment of Biochemistry, University of Otago, Dunedin, New Zealand tony.merriman@otago.ac.nz.
University of Otago · NZQueen Elizabeth Hospital · AUInserm · FRInstitute of Genetics and Cancer · GBNestlé (Switzerland) · CHRadboud University Nijmegen · NLRepatriation General Hospital · AURijnstate Hospital · NLUniversity Hospital Carl Gustav Carus · DEUniversity Medical Center Utrecht · NLUniversity of Auckland · NZUniversity of Engineering and Technology Lahore · PK

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and BloodR01HL087641 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2006 to 2008
$3.7M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
COMMUNITY AND COHORT SURVEILLANCE PROGRAMS-N01HC55015N01HC055015 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CHAMBLESS, LLOYD E · 1985 to 2006
$1.1M
COMMUNITY AND COHORT SURVEILLANCE PROGRAMN01HC055016 · HC · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE M · 1985 to 2000
$785k
FIELD CENTER FOR CCSPN01HC055019 · HC · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FOLSOM, AARON R · 1985 to 2000
$748k
FIELD CENTERN01HC055021 · HC · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI JONES, DANIEL W · 1985 to 2000
$617k
CCSP-FIELD CENTERN01HC055020 · HC · JOHNS HOPKINS UNIVERSITY · PI NIETO, F JAVIER · 1985 to 2000
$334k
CENTRAL HEMOSTATIS LABORATORY FOR CCSPN01HC055022 · HC · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WU, KENNETH K · 1985 to 2000
$264k
CCSP--FIELD CENTER AND ULTRASOUND READING CENTERN01HC055018 · HC · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI HEISS, GERARDO · 1985 to 2000
$104k
NCRR NIH HHS UL1 RR025005NHGRI NIH HHS U01 HG004402NHLBI NIH HHS N01 HC055015NHLBI NIH HHS N01 HC055016NHLBI NIH HHS N01 HC055018NHLBI NIH HHS N01 HC055019NHLBI NIH HHS N01 HC055020NHLBI NIH HHS N01 HC055021NHLBI NIH HHS N01 HC055022NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01 HL087641
6 · The paper itself

Abstract

objectiveGout is associated with dyslipidaemia. Association of the apolipoprotein A1-C3-A4 gene cluster with gout has previously been reported in a small study. To investigate a possible causal role for this locus in gout, we tested the association of genetic variants from APOA1 (rs670) and APOC3 (rs5128) with gout.

methodsWe studied data for 2452 controls and 2690 clinically ascertained gout cases of European and New Zealand Polynesian (Māori and Pacific) ancestry. Data were also used from the publicly available Atherosclerosis Risk in Communities study (n = 5367) and the Framingham Heart Study (n = 2984). Multivariate adjusted logistic and linear regression was used to test the association of single-nucleotide polymorphisms with gout risk, serum urate, triglyceride and high-density lipoprotein cholesterol (HDL-C).

resultsIn Polynesians, the T-allele of rs670 (APOA1) increased (odds ratio, OR = 1.53, P = 4.9 × 10(-6)) and the G-allele of rs5128 (APOC3) decreased the risk of gout (OR = 0.86, P = 0.026). In Europeans, there was a strong trend to a risk effect of the T-allele for rs670 (OR = 1.11, P = 0.055), with a significant protective effect of the G-allele for rs5128 being observed after adjustment for triglycerides and HDL-C (OR = 0.81, P = 0.039). The effect at rs5128 was specific to males in both Europeans and Polynesians. Association in Polynesians was independent of any effect of rs670 and rs5128 on triglyceride and HDL-C levels. There was no evidence for association of either single-nucleotide polymorphism with serum urate levels (P ⩾ 0.10).

conclusionOur data, replicating a previous study, supports the hypothesis that the apolipoprotein A1-C3-A4 gene cluster plays a causal role in gout.

Indexed as

AdultApolipoprotein A-IApolipoprotein C-IIIApolipoproteins CCase-Control StudiesFemaleGenotypeGoutHumansMaleMiddle AgedMultigene FamilyRisk FactorsUric AcidWhite PeopleAPOA1 protein, humanAPOC4 protein, humanApolipoprotein A-IApolipoprotein C-IIIApolipoproteins CUric Acidapolipoproteinassociationgenegouthyperuricaemia

Identifiers

PMID27094595
PMCPMC5854033
OpenAlexW2336129981

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.